rss
Br J Ophthalmol 2003;87:1397-1398 doi:10.1136/bjo.87.11.1397
  • Laboratory science - Scientific reports

Mycophenolate mofetil inhibits human Tenon fibroblast proliferation by guanosine depletion

  1. C Heinz,
  2. K Heise,
  3. T Hudde,
  4. K-P Steuhl
  1. Department of Ophthalmology, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany
  1. Correspondence to: Carsten Heinz MD, Department of Ophthalmology, University Essen, Hufelandstrasse- 55, 45122Essen, Germany; carsten.heinzgmx.net
  • Accepted 23 March 2003

Abstract

Backgroundaim: Mycophenolate mofetil could be a useful antiproliferative drug in glaucoma filtering surgery. In this study the authors set out to investigate whether growth inhibition of mycophenolate mofetil on human Tenon fibroblasts is mediated by guanosine depletion.

Methods: Cultured human Tenon fibroblasts were incubated in various concentrations of mycophenolate mofetil with and without supplementation of guanosine.

Results: Growth inhibition was concentration dependent. The effect could be completely antagonised by guanosine supplement.

Conclusion: Human Tenon fibroblasts depend on the de novo synthesis pathway of guanosine. No sufficient salvage pathway from purine degradation appears to exist.

Footnotes

    This Article

    Services

    1. Request permissions

    Responses

    1. Submit a response
    2. No responses published

    Social bookmarking

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Free archive
    The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.